Skip to content

Research at St Andrews

Alzheimer's disease in humans and other animals: a consequence of postreproductive life span and longevity rather than aging

Research output: Research - peer-reviewArticle

DOI

Author(s)

Danielle Gunn-Moore, Oksana Kaidanovich-Beilin, Maria Carolina Gallego Iradi, Frank Gunn-Moore, Simon Lovestone

School/Research organisations

Abstract

Introduction Alzheimer's disease and diabetes mellitus are linked by epidemiology, genetics, and molecular pathogenesis. They may also be linked by the remarkable observation that insulin signaling sets the limits on longevity. In worms, flies, and mice, disrupting insulin signaling increases life span leading to speculation that caloric restriction might extend life span in man. It is our contention that man is already a long-lived organism, specifically with a remarkably high postfertility life span, and that it is this that results in the prevalence of Alzheimer's disease and diabetes.

Methods We review evidence for this hypothesis that carries specific predictions including that other animals with exceptionally long postreproductive life span will have increased risk of both diabetes and Alzheimer's disease.

Results and Conclusions We present novel evidence that Dolphin, like man, an animal with exceptional longevity, might be one of the very few natural models of Alzheimer's disease.
Close

Details

Original languageEnglish
Pages (from-to)195-204
JournalAlzheimer's and Dementia
Volume14
Issue number2
Early online date30 Sep 2017
DOIs
StatePublished - Feb 2018

    Research areas

  • Longevity, Insulin signaling, Alzheimer's pathology, Animal models, Tau, Amyloid, GSK-3

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual Inhibitors of Casein Kinase 1 and ABAD Enzymes for Treatment of neurodegenerative Disorders

    Benek, O., Hroch, L., Aitken, L., Gunn-Moore, F. J., Vinklarova, L., Kuca, K., Pereze, D. I., Perezf, C., Martinez, A., Fisar, Z. & Musilek, K. 21 Feb 2018 (Accepted/In press) In : Journal of Enzyme Inhibition and Medicinal Chemistry.

    Research output: Research - peer-reviewArticle

  2. In vitro assay development and HTS of small molecule human ABAD/17β-HSD10 inhibitors as therapeutics in Alzheimer’s Disease

    Aitken, L., Baillie, G., Pannifer, A., Morrison, A., Jones, P. S., Smith, T. K., McElroy, S. P. & Gunn-Moore, F. J. Jul 2017 In : SLAS Discovery. 22, 6, p. 676-685 11 p.

    Research output: Research - peer-reviewArticle

  3. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: design, synthesis and in vitro evaluation

    Benek, O., Hroch, L., Aitken, L., Dolezal, R., Guest, P., Benkova, M., Soukup, O., Musil, K., Hughes, R., Kuca, K., Smith, T. K., Gunn-Moore, F. & Musilek, K. Jun 2017 In : Medicinal Chemistry. 13, 4, p. 345-358 14 p.

    Research output: Research - peer-reviewArticle

  4. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment

    Hroch, L., Guest, P., Benek, O., Soukup, O., Janockova, J., Dolezal, R., Kuca, K., Aitken, L., Smith, T. K., Gunn-Moore, F., Zala, D., Ramsay, R. R. & Musilek, K. 1 Feb 2017 In : Bioorganic & Medicinal Chemistry. 25, 3, p. 1143-1152 10 p.

    Research output: Research - peer-reviewArticle

  5. Crumbs 3b promotes tight junctions in an ezrin-dependent manner in mammalian cells

    Tilston-Lunel, A. M., Haley, K., Schlecht, N., Wang, Y., Chatterton, A. L. D., Moleirinho, S. L., Watson, A., Hundal, H., Prystowsky, M., Gunn-Moore, F. J. & Reynolds, P. A. Oct 2016 In : Journal of Molecular Cell Biology. 8, 5, p. 439-455

    Research output: Research - peer-reviewArticle

Related by journal

  1. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach

    Posner, H. B., Cano, S., Carrillo, M. C., Selnes, O., Stern, Y., Thomas, R. G., Zajicek, J., Hobart, J. & Alzheimer's Disease Neuroimaging Initiative Feb 2013 In : Alzheimer's and Dementia. 9, 1 Suppl, p. S56-60

    Research output: Research - peer-reviewArticle

  2. Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods

    Hobart, J., Cano, S., Posner, H., Selnes, O., Stern, Y., Thomas, R., Zajicek, J. & Alzheimer's Disease Neuroimaging Initiative Feb 2013 In : Alzheimer's and Dementia. 9, 1 Suppl, p. S4-9

    Research output: Research - peer-reviewArticle

  3. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory

    Hobart, J., Cano, S., Posner, H., Selnes, O., Stern, Y., Thomas, R., Zajicek, J. & Alzheimer's Disease Neuroimaging Initiative Feb 2013 In : Alzheimer's and Dementia. 9, 1 Suppl, p. S10-20

    Research output: Research - peer-reviewArticle

ID: 251063486